Lipilisi 1: Selelekela sa Peptide Purity & Tatelano Botšepehi
Peptide synthesis ka Solid-Phase Peptide Synthesis (SPSS) kapa ho belisoa ha likokoana-hloko ka tlhaho ho hlahisa litšila tse amanang haufi-ufi. Lisebelisoa tsa radiopharmaceutical, litšila tse nyane tsa peptide li ka khopamisa kinetics ea radiolabeling kapa tsa qothisana lehlokoa ka kotloloho le peptide e tlamang tumor receptor..
Key Takeaway: A 95% bohloeki bo felletseng ho CoA ha bo na moelelo haeba ho setseng 5% e na le tatelano ea ho hlakola e tlamang ntle le khetho kapa li-counter tse sitisang radiolabeling pH le khokahano..
Mekhoa e Tloaelehileng ea ho hloleha
- Co-Eluting Hlakola Litšila (n-1, n-2): Likaroloana tsa tatellano e khutsufalitsoeng tse hlahisitsoeng nakong ea mehato ea ho kopanya (mohlala, libakeng tse hokahaneng tse telele tsa PSMA-617 kapa cyclic octapeptide tatelano ea DOTA-TATE) hangata ba arolelana hydrophobicity e batlang e ts'oana le peptide ea bolelele bo felletseng, co-eluting nakong e tloaelehileng ea Reverse-Phase HPLC (RP-HPLC).
- Amino Acid Racemization: Epimerization ho masala a tloahelehileng ho merabe (joalo ka Cysteine, Tryptophan, kapa Histidine) e fetola sebopeho sa mahlakore a mararo, ho fokotsa kamano ea li-receptor kapa ho sitisa phihlello ea chelator.
- Trifluoroacetic acid (TFA) Counterion Toxicity: TFA e setseng e setseng ho tsoa ho li-cocktails tsa cleavage e fetola pH nakong ea radiolabeling mme e baka chefo ea cellular ho in vitro le litekong tsa vivo..
- Gross Mass vs. Net Peptide Content Mismatch: Lyophilized peptide powders e na le mongobo o setseng, counterions, le matsoai. Ho itšetleha ka boima ba 'mele ho e-na le ho ba le peptide e ngata ho fella ka lipalo tse sa nepahalang tsa ts'ebetso ea molar nakong ea ho ngola..
Litlhahlobo tse khothalelitsoeng tsa Analytical
- Orthogonal RP-HPLC / UHPLC Profileing: Sebelisa mekhahlelo e meng ea ho ema (joalo ka likholomo tsa C18 le Phenyl-Hexyl) ka pH e tlase ebile e sa nke lehlakore ho rarolla li-diastereomer le tatelano ea ho hlakola.
- Boima ba Boima ba Boipheliso bo Phahameng (LC-ESI-HRMS): Netefatsa boima bo nepahetseng ba monoisotopic 'me u latelle litšila tsa profil ho ea ho 0.1% moeli oa sebaka.
- Ion Chromatography (KEA BONA): Lekanya li-counterions tse setseng (TFA, acetate, chloride) ho netefatsa phetoho e felletseng ya counterion.
- Amino Acid Analysis (AAA): Lekanya litaba tsa peptide tse nepahetseng ho thusa stoichiometry e nepahetseng nakong ea karabelo ea radiolabeling.
Mehato ea Litlhaloso tsa barekisi
Ha ho theha Litumellano tsa Boleng bakeng sa phepelo ea selelekela sa tloaelo, ho phethahatsa mekhoa ena ea motheo:
- RP-HPLC Bohloeki: ≥ 95.0% bakeng sa tlhahlobo ea pele; ≥ 98.0% bakeng sa lihlopha tsa IND-enable/clinical.
- Ho se hloeke ho phahameng ho le Mong: < 0.5% sebaka ka RP-HPLC.
- Litaba tse setseng tsa TFA: < 1.0% w/w (ka phapanyetsano e ratoang ea acetate kapa hydrochloride).
- Net Peptide Content: E hlalositsoe ke AAA (hangata 80-90% bakeng sa letsoai la lyophilized).
Peptide Synthesis Ha ho rekoa tatellano e rarahaneng ea sepheo - joalo ka li-precursors tsa PSMA-617 kapa DOTA-TATE - ho theha litumellano tse matla tsa boleng ba barekisi bakeng sa tloaelo ea peptide synthesis le analytical QC e etsa bonnete ba hore profiling ea orthogonal HPLC le liprothokholo tsa phapanyetsano ea counterion li netefalitsoe ka botlalo pele batch e lokolloa..
Lipilisi 2: Conjugation Site Mapping & Chelator Botšepehi
Li-chelator tse sebetsang habeli—joaloka DOTA, SEBELISA, DOTAGA, kapa NODA-MP-NCS-li kopantsoe le mokokotlo oa peptide ebang ke nakong ea motsoako o tiileng kapa ka post-synthetic bioconjugation.. Regioselective e nepahetseng ke ea bohlokoa: chelator e hokelletsoeng ho masala a Lysine kapa Cysteine a ka felisang ts'ebetso ea tlhaho ka botlalo..
[Target Peptide Backbone] [Bifunctional Linker] [Macrocyclic Chelator (TLHOKOMELO/TLHOKOMELO)]
Mekhoa e Tloaelehileng ea ho hloleha
- Regioisomeric Ambiguity: Khokahano e sa tobang nakong ea bioconjugation (mohlala, Sehokelo sa DOTA holim'a liketane tse lehlakoreng la Lysine kapa maemo a li-linker amine ho DOTA-TATE le PSMA-617), ho hlahisa li-regioisomers tse nang le kinetics e tlamang e fetotsoeng haholo.
- Ho Kopanya ho Feta (Lisebelisoa tsa Multi-Chelator): Tšireletso e sa phethahalang ea ketane ea mahlakoreng e bakang hore li-peptide li be teng Li-Peptide tsa Synthetic likarolo tse peli kapa ho feta tsa chelator (di-DOTA kapa mefuta e meraro ea DOTA), e fetolang biodistribution le pharmacokinetics.
- Ho senyeha ha Ring ea Hydrolytic: Hydrolysis kapa intramolecular ring-opening ea reactive chelator anhydrides kapa esters e sebetsang pele ho conjugation, ho bopa tse sa sebetseng kapa tse rarahanang ka thata.
- Trace Metal Chefo: Ho silafatsoa ke li-ion tsa tšepe tse se nang mahlaseli (joalo ka Fe³⁺, Zn²⁺, Cu²⁺, kapa Al³⁺) ho tsoa ho li-reagents, lisebelisoa tsa khalase, kapa litšiea tsa tlhoekiso. Trace metals ka potlako e nka macrocyclic chelators, ho thibela ho kenngoa ha radiometal ea phekolo.
Litlhahlobo tse khothalelitsoeng tsa Analytical
- Tandem LC-MS/MS Peptide Mapping: Etsa Karohano e Bakiloeng ke Khohlano (CID) kapa Electron Transfer Dissociation (ETD) tandem mass spectrometry ho tatellano ea li-ion tsa peptide le ho etsa 'mapa ka mokhoa o hlakileng boemo ba amino acid ea chelator..
- Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF-MS): Ka potlako netefatsa kabo ea boima ba limolek'hule 'me u netefatse ho ba sieo ka ho feletseng ha mefuta e mengata ea lisebelisoa.
- Ka mokhoa o ts'oanang, plasma Mass Spectrometry (ICP-MS): Ho hlahloba li-batch tsa precursor bakeng sa maemo a sub-ppm a litšila tsa tšepe tsa phetoho pele ho radiolabeling..
⚠️ Tlhokomeliso: Karolo e le 'ngoe ho milione (ppm) boemo ba Iron (Fe³⁺) kapa Zinc (Zn²⁺) a precursor batch ka fokotsa lihlahisoa tsa radiochemical ka ho feta 40% ka lebaka la khokahano ea tlholisano e khethehileng ho feta Lutetium-177 kapa Actinium-225.
Mehato ea Litlhaloso tsa barekisi
- Regioselectivity: 100% sekhomaretsi se ikhethileng sa sebaka se netefalitsoeng ke karohano ea MS/MS.
- Mono-Conjugated Mefuta e Hloekileng: > 98.0% litaba tsa mono-chelator; mefuta ea di-chelator < 0.2%.
- Chelator ea mahala e sa sebetseng: < 0.5% sebaka.
- Latela Lintho tse Boima tsa Metal (Fe, Zn, Cu, Pb): < 0.1 ppm motho ka mong, < 0.5 ppm kakaretso e lekantsoeng ka ICP-MS.
Bakeng sa lik'hemik'hale tse khethehileng tsa bioconjugation, ho sebelisa e khethehileng khokahano ea chelator ea sebaka se ikhethileng workflow e tiisa stoichiometry e nepahetseng 'me e felisa li-adducts tse seng tse tobileng tsa lehlakoreng.
Lipilisi 3: Bohloeki ba Radiochemical (RCP) & Isotope Incorporation
Hang ha peptide-chelator conjugate e kenngoa ka radionuclide (mohlala, 177LuCl₃ kapa 225AcNO₃), ho netefatsa ho kenngoa ha isotope le bohloeki ba radiochemical (RCP) ke tlhoko ea mantlha ea tokollo bakeng sa litokisetso tsa radiopharmaceutical.
Mekhoa e Tloaelehileng ea ho hloleha
- Radimetal Complexation e sa Feleng: Kotulo e tlase ea radiochemical e siea e sa rarahana, radionuclide mahala ka tharollo, e isang pokeletsong ya setho se sa lebelloang (mohlala, khatello ea masapo ho tloha mahala 177Lu kapa mahala 225Ac ho bola barali).
- Colloidal Radiometal Formation: Li-radiometals tse etsang li-insoluble hydroxide colloids ka pH e phahameng, e kganyang maboteng a vial kapa e bokellang sebeteng nakong ya tsamaiso ya mmele.
- Radio-TLC Overstimation: E itšetlehile feela ka Instant Thin-Layer Chromatography (Radio-ITLC) bakeng sa tlhahlobo ea tokollo. Radio-ITLC hangata e hloleha ho rarolla likhechana tsa radiolytic kapa lihlahisoa tse nyane tse senyehileng tsa peptide ho tsoa ho radioligand e sa fetoheng., e lebisang liphellong tsa bohloeki bo fosahetseng.
Litlhahlobo tse khothalelitsoeng tsa Analytical
- Radio-HPLC / Radio-UHPLC e nang le li-radiodetectors tsa Marang-rang: Kopanya chromatography ea mokelikeli e nang le qeto e phahameng le gamma, beta, kapa ho lemoha ka tšohanyetso radio-detection. Joalo ka ha ho hlalositsoe liphuputsong tse hatisitsoeng ka Radio-HPLC analytical protocols bakeng sa taolo ea boleng ba radiopharmaceutical, Radio-HPLC e tlamehile ho arola lihlahisoa tsa radiolytic cleavage ho li-conjugate tse sa sebetseng tsa radiolabele..
- Radio-ITLC ea Dual System: Sebelisa litsamaiso tse peli tsa orthogonal mobile/stationary phase (mohlala, Silica gel ITLC e nang le Ammonium Acetate:Methanol bakeng sa tšepe ea mahala, le Citrate buffer bakeng sa mefuta ea colloidal) joalo ka tlhahlobo ea netefatso ea bobeli e potlakileng.
Mehato ea Litlhaloso tsa barekisi
- Radio-HPLC Radiochemical Purity: ≥ 95.0% bakeng sa tokollo (≥ 98.0% e reretsoeng tsamaiso ea kliniki).
- Karolo ea mahala ea Radionuclide: < 1.0% mosebetsi o felletseng.
- Colloidal / Karolo ea Particulate: < 1.0% mosebetsi o felletseng.
Lipilisi 4: Radiolytic botsitso & Botšepehi ba Post-Labeling
Therapeutic alpha le beta emitters beha mahlaseli a matla a ionizing a sebakeng seo. Matla ana a hlahisa mefuta ea oksijene e sebetsang (ROS)- joalo ka li-radicals tsa hydroxyl (•OH), lielektrone tse nang le metsi, le oksijene ea singlet-e hlaselang ka ho toba mokokotlo oa peptide le liketane tsa mahlakoreng a amino acid.
Ho senyeha ha Radionuclide (177Lu / 225Ac) → Moloko oa ROS → Oxidation ea Side-Chain (Met/Trp/His)
→ Mokokotlo Scission & Ho Vivo Dechelation
Mekhoa e Tloaelehileng ea ho hloleha
- Radiolytic Backbone Scission: Tlhaselo e matla e bakang ho petsoha ha li-bond tsa peptide amide nakong ea lihora tse ngata ka mor'a ho ngolisoa, ho hlahisa makumane a sa sebetseng kapa a chefo a radiolabeled.
- Side-Chain Oxidation: Methionine thioether oxidation ho sulfoxide/sulfone, kapa tryptophan pyrrole ring oxidation, e fokotsang kamano e tlamang ea li-receptor haholo.
- Ho Vivo Dechelation & Phetoho ea tšepe: Tšenyo ea mahlaseli ho selikalikoe sa chelator kapa botsitso bo fokolang ba khokahano bo lebisang tahlehelong ea isotope ho potoloha.. Joalo ka ha ho totobalitsoe litlhahlobong tsa mahlale ka botsitso ba chelator le tlhahlobo ea kotsi ea transmetallation, li-complexes tse sa tsitsang li lebisa tlhokomelong e matla ea moko oa masapo le chefo ea renal.
Litlhahlobo tse khothalelitsoeng tsa Analytical
- Teko ea Botsitso ea Nako-Course: Lekola bohloeki ba radiochemical ka Radio-HPLC ka linako tse hlalositsoeng tsa kamora ho ngola (t = 0, 2, 4, 24, le 48 lihora) tlas'a mocheso oa kamore le maemo a polokelo.
- Lithuto tsa Radical Scavenger Optimization: Lekola ts'ebetso ea ts'ireletso ea li-radical quenchers tsa mahala - joalo ka Ascorbic Acid, Asiti ea Gentic, le Ethanol—ka litekanyo tse sa tšoaneng tsa mahloriso.
- In Vitro Plasma Stability & Tlamang Ho boloka: Ho kenella ka har'a serum ea motho ka 37 ° C e lateloa ke liteko tse tlamang tsa radioligand ho netefatsa tlhokomelo ea kamano e tlamang. (Kd).
Bakeng sa Keletso: Kamehla etsa tlhahlobo ea khatello ea maikutlo ea radiolytic maemong a phahameng a volumetric (mohlala, 50-100 MBq/mL) nakong ea tlhahiso ea tlhahiso. Motsoako o tsitsitseng mesebetsing e tlase ea tlhahlobo e ka 'na ea fokotseha ka potlako maemong a matla a kalafo.
Mehato ea Litlhaloso tsa barekisi
- Tlhokomelo ea Bohloeki ba Radiochemical: ≥ 90.0% RCP ho 24 lihora tse kamora ho ngolisoa; ≥ 85.0% ho 48 lihora ka mocheso o khothalletsoang oa polokelo.
- Mefuta ea Peptide e Oxidized: < 2.0% kakaretso ea tlhoro ea sebaka ka boteng ba optimized radical scavengers.
- Receptor Binding Affinity Retention: Kd ka har'a 2-fold ea maemo a batang a se nang mahlaseli.
Merero ea taolo e totobatsa hore netefatso e felletseng ea tlhahlobo e tlameha ho ikamahanya le European Medicines Agency tataiso ea taolo bakeng sa litšila le litlhaloso tsa maiketsetso tsa peptide, ho netefatsa hore selelekela sa botsitso le mekhoa ea tlhahlobo e lumellana le litebello tsa taolo ea machaba.
Kakaretso ea RLT Peptide QC Litlhaloso Kakaretso Letlapa
| Bokhoni ba ho Hlahlobisisa | Mokhoa oa ho hloleha oa mantlha | E khothalelitsoeng Analytical Assay | Morekisi / Tekanyetso ea Litlhaloso tsa Batch |
|---|---|---|---|
| Peptide Precursor Bohloeki | Co-eluting tatellano ea ho hlakola, li-diastereomer, TFA chefo Tlhahiso ea Peptide | Orthogonal RP-HPLC (C18 & Phenyl-Hexyl), LC-ESI-HRMS, Ion Chromatography | HPLC Bohloeki ≥ 95.0% (IND: ≥ 98.0%); Tšilafalo e le 'ngoe < 0.5%; TFA < 1.0% |
| Conjugation Site Mapping | Regioisomeric mescoupling, ho kopanya hofeta tekanyo, chelator hydrolysis | Tandem LC-MS/MS ('Mapa oa CID/ETD), MALDI-TOF-MS | 100% Regioselectivity; Mono-chelator > 98.0%; Chelator e sa sebetseng < 0.5% |
| Trace Metal Screening | Chelator e chefo ka li-ion tsa tlholisano (Fe³⁺, Zn²⁺, Cu²⁺) | ICP-MS trace elemental analysis | Fe, Zn, Cu < 0.1 ppm motho ka mong, < 0.5 ppm kakaretso |
| Bohloeki ba Radiochemical (RCP) | Ho rarahana ha radiometal e sa fellang, toxicity ea isotope e sa lefelloeng | Radio-HPLC e nang le mochine oa gamma/beta, Radio-ITLC ea Dual System | Radio-HPLC RCP ≥ 95.0% (Sepheo: ≥ 98.0%); Radiometal ea mahala < 1.0% |
| Radiolytic botsitso | Amide cleavage e bakoang ke mahlaseli, Met/Trp oxidation | Nako ea nako Radio-HPLC (0-48 h), Radical scavenger optimization | RCP ≥ 90.0% ho 24 h post-labeling; Mefuta e nang le oxidized < 2.0% |
Ho sebelisana le Lihlopha tse Khethehileng tsa Ntlafatso ea Peptide
Ho lebella liphephetso tsa tlhahlobo pele ho nts'etsopele ho fetola tlhahiso ea radiopharmaceutical ho tloha ts'ebetsong e sa lebelloang ea teko le liphoso hore e be e ka hlahisoang hape., saense e itokiselitseng sekala.
Ha o nts'etsapele bonkgetheng ba radiopharmaceutical ho tloha ho sibollo e reriloeng ho isa lithutong tse thusang IND, ho sebelisa e khethehileng peptide CRO le sethala sa nts'etsopele ea ts'ebetso etsa bonnete ba hore tatellano optimization, bioconjugation e khethehileng ea sebaka, 'me litlhaloso tse matla tsa tlhahlobo li hahiloe ka kotloloho k'hemistri ea hau, tlhahiso, le ditaolo (CMC) moralo.
Liphetoho tsa MOL li fana ka mokhoa oa ho qetela ho isa qetellong oa peptide synthesis le lits'ebeletso tse rarahaneng tsa bioconjugation ka har'a Sehlopha 100 libaka tse hloekileng tsa phaposi e hloekileng. E tšehetsoa ke LC-MS/MS e tsoetseng pele, orthogonal HPLC, le tlhahlobo e felletseng ea tlhahlobo, sehlopha sa rona se matlafatsa baetsi ba biopharma ho fana ka lintho tse hloekileng haholo, stably conjugated radiopharmaceutical precursors tse nang le ponaletso e felletseng ea tlhahlobo.
Lipotso Tse Botsoang Khafetsa (LBH)
Hobaneng ho hloeka ha HPLC feela ho sa lekana bakeng sa li-precursors tsa radiopharmaceutical peptide?
HPLC e tloaelehileng e lekanya ho monya ha UV ho 214 nm kapa 220 nm, e bonts'ang ho monya ha mokokotlo oa peptide empa e sa khone ho khetholla lipakeng tsa li-regioisomers kapa ho netefatsa libaka tse khomaretsoeng tsa chelator.. Ho feta moo, Bohloeki ba UV ha bo ikarabelle bakeng sa litšila tsa tšepe tse sa monyeng (joalo ka Fe³⁺ kapa Zn²⁺) kapa li-counterions tsa TFA, tseo ka bobeli li senyang lihlahisoa tsa radiolabeling haholo le polokeho ea liselefouno.
Radio-HPLC e fapana joang le Radio-ITLC tlhahlobong ea bohloeki ba radiochemical?
Radio-ITLC e arola lik'hemik'hale tse ipapisitseng le phallo e bonolo holim'a lesela, e ntle haholo bakeng sa tlhahlobo e potlakileng ea ho feta / e hlolehang ea radiometal ea mahala. Leha ho le joalo, Radio-ITLC ha e na qeto ea chromatographic e hlokahalang ho arola li-peptide tse sa fetoheng tse nang le radiolabeled ho tsoa ho likhechana tse senyehileng tsa radiolytic kapa mefuta e nang le oxidized.. Radio-HPLC e sebelisa likholomo tsa mokelikeli oa chromatography tse kopantsoeng le lisebelisoa tsa mahlaseli a marang-rang ho rarolla le ho lekanya mefuta eohle e ngotsoeng ka radiolabele ka nepo..
Ke li-radical scavengers tse sebetsang haholo ho thibela ho senyeha ha radiolytic?
Ascorbic acid, asiti ea gentic, 'me ethanol ke tsona tse netefalitsoeng ka ho fetesisa tsa radiolytic scavengers bakeng sa kalafo ea radioligand. Ba sebetsa ka ho tima ka potlako li-radicals tsa hydroxyl le lielektrone tsa hydrate tse hlahisoang nakong ea radiolysis pele li-radicals tseo li ka sebetsana le mesaletsa e bobebe ea peptide. (joalo ka methionine, Tryptophan, le Histidine) kapa mokokotlo oa chelator.
Li-peptide tse tlang pele li lokela ho bolokoa joang ho boloka botsitso ba chelator ea nako e telele?
Li-conjugate tsa Peptide-chelator (joalo ka li-precursors tsa DOTA-TATE kapa PSMA-617) e lokela ho bolokoa e le lyophilized e le li-aliquot tse nyopa tlas'a khase ea inert (argon kapa naetrojene) mocheso -20 ho ea ho -80°C. Ho qoba lipotoloho tse pheta-phetoang tsa leqhoa le ho sireletsa selelekela ho tloha mongobo oa sepakapaka ho thibela hydrolytic degradation ea macrocyclic chelators le side-chain oxidation pele ho radiolabeling..
